Jeffrey McBride to Janus Kinase Inhibitors
This is a "connection" page, showing publications Jeffrey McBride has written about Janus Kinase Inhibitors.
Connection Strength
0.042
-
Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19. Clin Dermatol. 2020 Nov-Dec; 38(6):775-780.
Score: 0.042
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.